Active Ingredient History

  • Now
Anacetrapib is a CETP inhibitor which was being developed to treat elevated cholesterol levels in an effort to prevent cardiovascular disease. In 2017 its development was abandoned by Merck.   Wikipedia

  • SMILES: COc1cc(F)c(cc1c2ccc(cc2CN3[C@@H](C)[C@H](OC3=O)c4cc(cc(c4)C(F)(F)F)C(F)(F)F)C(F)(F)F)C(C)C
  • Mol. Mass: 637.51
  • ALogP: 9.76
  • ChEMBL Molecule:
More Chemistry
anacetrapib | mk0859 | mk 0859 | mk-0859


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue